Patent ID: 9522132
Filing Date: 2016-12-20
CPC Classification: A23K,A23L,A23V,A61K,A61P

Claim Text:
1. A method for lowering an inflammation response in an individual having multiple sclerosis and a condition selected from the group consisting of lipid maldigestion, lipid malabsorption, and a combination thereof, the method comprising: administering a composition comprising sn-2 monoacylglycerol, wherein the sn-1 and sn-3 positions are blocked by protective groups and the acyl group is a fatty acid having anti-inflammatory properties selected from the group consisting of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), α-linolenic acid (ALA), stearidonic acid (SA), γ-linolenic acid (GLA), dihomo-γ-linolenic acid (DGLA), n-3 docosapentanenoic acid (DPA), sciadonic acid and juniperonic acid, to an individual in need of same.